139 related articles for article (PubMed ID: 38135543)
1. Brain Metastases in the Setting of Stable Versus Progressing Extracranial Disease Among Patients With Metastatic Breast Cancer.
Kojundzic I; Chehade R; Gonzalez CAC; Fritz J; Moravan V; Sahgal A; Warner E; Das S; Jerzak KJ
Clin Breast Cancer; 2024 Feb; 24(2):156-161. PubMed ID: 38135543
[TBL] [Abstract][Full Text] [Related]
2. Treatment Patterns and Outcomes of Women with Symptomatic and Asymptomatic Breast Cancer Brain Metastases: A Single-Center Retrospective Study.
Gao YK; Kuksis M; Id Said B; Chehade R; Kiss A; Tran W; Sickandar F; Sahgal A; Warner E; Soliman H; Jerzak KJ
Oncologist; 2021 Nov; 26(11):e1951-e1961. PubMed ID: 34506676
[TBL] [Abstract][Full Text] [Related]
3. Human Epidermal Growth Factor Receptor 2-Low Breast Cancer Brain Metastases: An Opportunity for Targeted Systemic Therapies in a High-Need Patient Population.
Chehade R; Nofech-Mozes S; Plotkin A; Fan KY; Das S; Sahgal A; Moravan V; Jerzak KJ
JCO Precis Oncol; 2024 Mar; 8():e2300487. PubMed ID: 38547418
[TBL] [Abstract][Full Text] [Related]
4. Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer.
Id Said B; Soliman H; Moravan V; Myrehaug S; Tseng CL; Detsky J; Sahgal A; Warner E; Jerzak KJ
J Neurooncol; 2023 Sep; 164(2):437-445. PubMed ID: 37634217
[TBL] [Abstract][Full Text] [Related]
5. Triple Negative Breast Cancer and Brain Metastases.
Bansal R; Van Swearingen AED; Anders CK
Clin Breast Cancer; 2023 Dec; 23(8):825-831. PubMed ID: 37586926
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Rates of Brain Metastases and Association With Breast Cancer Subtypes in Ontario, Canada.
Wang XY; Rosen MN; Chehade R; Sahgal A; Das S; Warner E; Saskin R; Zhang B; Soliman H; Chan KKW; Jerzak KJ
JAMA Netw Open; 2022 Aug; 5(8):e2225424. PubMed ID: 35960523
[TBL] [Abstract][Full Text] [Related]
7. Exclusion of Patients With Brain Metastases in Published Phase III Clinical Trials for Advanced Breast Cancer.
Sharma A; Searle K; Hasan S; Chan S; Pond G; Jerzak KJ
Clin Breast Cancer; 2022 Oct; 22(7):629-633. PubMed ID: 35965204
[TBL] [Abstract][Full Text] [Related]
8. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
Anders CK; Deal AM; Miller CR; Khorram C; Meng H; Burrows E; Livasy C; Fritchie K; Ewend MG; Perou CM; Carey LA
Cancer; 2011 Apr; 117(8):1602-11. PubMed ID: 21472708
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.
Priedigkeit N; Hartmaier RJ; Chen Y; Vareslija D; Basudan A; Watters RJ; Thomas R; Leone JP; Lucas PC; Bhargava R; Hamilton RL; Chmielecki J; Puhalla SL; Davidson NE; Oesterreich S; Brufsky AM; Young L; Lee AV
JAMA Oncol; 2017 May; 3(5):666-671. PubMed ID: 27926948
[TBL] [Abstract][Full Text] [Related]
10. Treating Brain Metastases from Breast Cancer: Outcomes after Stereotactic Radiosurgery.
Wilson TG; Robinson T; MacFarlane C; Spencer T; Herbert C; Wade L; Reed H; Braybrooke JP
Clin Oncol (R Coll Radiol); 2020 Jun; 32(6):390-396. PubMed ID: 32131980
[TBL] [Abstract][Full Text] [Related]
11. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
Dyer MA; Kelly PJ; Chen YH; Pinnell NE; Claus EB; Lee EQ; Weiss SE; Arvold ND; Lin NU; Alexander BM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e479-86. PubMed ID: 22704705
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 expression in breast cancer brain metastases.
Chehade R; Qazi MA; Ennis M; Sahgal A; Das S; Nofech-Mozes S; Jerzak KJ
Neurooncol Adv; 2022; 4(1):vdac154. PubMed ID: 36299795
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors and Survival According to Tumor Subtype in Women With Breast Cancer Brain Metastases.
Lopes S; Vieira I; Abreu M; Pousa I; Ferreira A; Sousa S; Pereira D
Curr Probl Cancer; 2022 Dec; 46(6):100866. PubMed ID: 36179388
[TBL] [Abstract][Full Text] [Related]
14. Androgen Receptor Is Expressed in the Majority of Breast Cancer Brain Metastases and Is Subtype-Dependent.
Fan KY; Chehade R; Qazi M; Moravan V; Nofech-Mozes S; Jerzak KJ
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345085
[TBL] [Abstract][Full Text] [Related]
15. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
[TBL] [Abstract][Full Text] [Related]
16. Management of Brain and Leptomeningeal Metastases from Breast Cancer.
Pellerino A; Internò V; Mo F; Franchino F; Soffietti R; Rudà R
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198331
[TBL] [Abstract][Full Text] [Related]
17. Medical treatment of brain metastases from solid tumours.
Cappuzzo F; Mazzoni F; Maestri A; Di Stefano A; Calandri C; Crino L
Forum (Genova); 2000; 10(2):137-48. PubMed ID: 10875975
[TBL] [Abstract][Full Text] [Related]
18. Available Systemic Treatments and Emerging Therapies for Breast Cancer Brain Metastases.
Rader RK; Anders CK; Lin NU; Sammons SL
Curr Treat Options Oncol; 2023 Jun; 24(6):611-627. PubMed ID: 37071254
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases.
Bottosso M; Griguolo G; Sinoquet L; Guarascio MC; Aldegheri V; Miglietta F; Vernaci G; Barbieri C; Girardi F; Jacot W; Guarneri V; Darlix A; Dieci MV
Br J Cancer; 2023 Mar; 128(7):1286-1293. PubMed ID: 36717671
[TBL] [Abstract][Full Text] [Related]
20. Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study.
Martin AM; Cagney DN; Catalano PJ; Warren LE; Bellon JR; Punglia RS; Claus EB; Lee EQ; Wen PY; Haas-Kogan DA; Alexander BM; Lin NU; Aizer AA
JAMA Oncol; 2017 Aug; 3(8):1069-1077. PubMed ID: 28301662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
